A. Stravodimou

Discipline

Psychology (4) Communication sciences (1)

Type

Articles (19) Reviews (8)

Co-author

Date

Source

Keyword

cancer (13) Cancer (13) Patients (13) Cancer (13) Patients (13) Breast (12) Treatment (10) oncology (7) Oncology (7) Human beings (7) Article (6) Grammar, Comparative and general--Article (6) Article (6) Chemotherapy (5) Chemotherapy (5) therapy (4) Methods (4) Year (4) Therapeutics (4) Cells (4) Cancer--Patients (4) Methods (4) Use (4) quality of life (3) management (3) gene (3) effect (3) approach (3) survival (3) Control (3)

Documents written by A. Stravodimou (19) | is about A. Stravodimou (0)

Homologous Recombination Defects and Mutations in DNA Damage Response (DDR) Genes Besides BRCA1 and BRCA2 as Breast Cancer Biomarkers for PARP Inhibitors and Other DDR Targeting Therapies.
I.A. Voutsadakis et al.
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
C. Bandiera et al. (Jan 3, 2023)
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
P. Courlet et al. (Jun 21, 2022)
Effets indésirables des nouvelles thérapies du cancer du sein : quand faut-il réagir ? [Adverse effects of new breast cancer therapies : when to react ?]
N. Dris et al. (May 18, 2022)
Oncologie [2021 Oncology update]
M.L. Meyer et al. (Feb 2, 2022)
Cancer du sein chez la femme en [Breast cancer during pregnancy]
M. Schnetz et al. (May 19, 2021)
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1.
G. Sflomos et al. (Mar 5, 2021)
Oncologie [2020 oncology update]
G. Dei Tos et al. (Jan 27, 2021)
Oncology during the COVID-19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients.
K. Tsamakis et al.
Cancer du sein: perspectives de médecine intégrative [Breast cancer: perspectives from integrative medicine]
A. Stravodimou et al. (May 27, 2020)
Oncologie [Advances in Oncology 2019]
A. Vernadou et al. (Jan 15, 2020)
Oncologie [Advances in Oncology 2019]
A. Vernadou et al. (Jan 15, 2020)
Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions.
M. Fiche et al.
Statin use and peripheral blood progenitor cells mobilization in patients with multiple myeloma.
A. Stravodimou et al. (2014)
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial.
E. Romano et al. (2014)
Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series
A. Stravodimou et al. (2014)
Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer
A. Stravodimou et al. (2013)
PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis.
A. Stravodimou et al. (2012)
Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer.
A. Stravodimou et al. (2012)